Skip to main content
HeartCited

Quy trình nghiên cứu

22 hình ảnh từ nghiên cứu có bình duyệt

Tất cả Coenzyme Q10 (CoQ10) Vitamin D Folate (Vitamin B9) Magnesium Potassium Calcium Selenium Resveratrol Quercetin Lycopene Berberine
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 6
Figure 6 Chart

Growth factor content and cell wall composition of different Chlorella species used in commercial supplements are compared.

Potential of Chlorella as a Dietary Supplement to Promote Human Health.

Figure 7
Figure 7 Chart

Safety assessment data for Chlorella supplementation, including heavy metal contamination screening and adverse event reporting from clinical trials.

Potential of Chlorella as a Dietary Supplement to Promote Human Health.

Figure 4
Figure 4 Chart

Population-level variation in folate-related genetic polymorphisms influences disease susceptibility across ethnic groups. This figure compares allele frequencies and associated health outcomes for key folate metabolism gene variants.

Genetic polymorphisms and folate status.

Figure 6
Figure 6 Chart

Body composition changes observed in participants following vegan dietary interventions are tracked over time, showing reductions in visceral adiposity and overall fat mass.

Vegan Diet Health Benefits in Metabolic Syndrome.

Figure 10
Figure 10 Chart

Insulin sensitivity indices before and after vegan dietary intervention are plotted, demonstrating improved glucose homeostasis in the plant-based diet group.

Vegan Diet Health Benefits in Metabolic Syndrome.

Figure 6
Figure 6 Chart

Gut microbiota composition analyzed by 16S rRNA sequencing reveals distinct community structures across treatment groups, with the combination therapy restoring microbial diversity.

The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver …

Figure 7
Figure 7 Chart

Alpha diversity indices of gut microbiota are compared across groups, indicating that berberine and evodiamine co-administration partially reverses high-fat diet-induced dysbiosis.

The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver …

Figure 8
Figure 8 Chart

Key bacterial taxa differentially abundant between treatment groups are identified, with specific genera associated with improved metabolic outcomes in the combination therapy arm.

The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver …

Figure 9
Figure 9 Chart

Short-chain fatty acid concentrations in fecal samples reflect changes in microbial metabolic activity following berberine and evodiamine treatment.

The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver …

Figure 10
Figure 10 Chart

Correlation analysis between gut microbiota composition and hepatic lipid parameters links specific bacterial taxa to the amelioration of non-alcoholic fatty liver disease.

The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver …

Figure 7
Figure 7 Chart

Evidence summary on the association between specific carotenoid compounds and Alzheimer's disease biomarkers. The data suggest that higher carotenoid status may be linked to reduced oxidative damage in neural tissues.

Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.

Figure 1. Blood pressure measurement (tail-cuff). Each bar represents values expressed as mean ± SEM. The change in mean arterial pressure (MAP) was considered significant (*) when p < 0.05 between two groups. The data were analyzed using two-way ANOVA
Figure 6 Chart

Blood pressure measurements by tail-cuff method showing significant changes in mean arterial pressure across treatment groups. Chronic metabolic acidosis elicited a hypertensive response, supporting the hypothesis that sustained acid-base imbalance directly contributes to elevated blood pressure.

Chronic Metabolic Acidosis Elicits Hypertension via Upregulation of Intrarenal Angiotensin II and …

Figure 7
Figure 7 Chart

Renal tissue analysis or additional hemodynamic data from the chronic metabolic acidosis hypertension study. The intrarenal measurements help delineate the local versus systemic mechanisms driving the blood pressure response.

Chronic Metabolic Acidosis Elicits Hypertension via Upregulation of Intrarenal Angiotensin II and …

Figure 8
Figure 8 Chart

Molecular or biochemical analysis of kidney tissue from animals with chronic metabolic acidosis. The data examine expression of inducible nitric oxide synthase and angiotensin pathway components in the renal cortex.

Chronic Metabolic Acidosis Elicits Hypertension via Upregulation of Intrarenal Angiotensin II and …

Figure 5. Urinary sodium analysis. Each bar represents values expressed as mean ± SEM. The change in urine sodium levels were considered significant (*) when p < 0.05 between groups. The data were analyzed using one-way ANOVA followed by Tukey’s multip
Figure 9 Chart

Urinary sodium excretion analysis across experimental groups reveals altered renal sodium handling during chronic metabolic acidosis. Changes in sodium reabsorption may contribute to the volume-dependent component of acidosis-induced hypertension.

Chronic Metabolic Acidosis Elicits Hypertension via Upregulation of Intrarenal Angiotensin II and …

Figure 6. Serum sodium and potassium levels. Each bar represents values expressed as mean ± SEM. (A) The changes in serum sodium levels were considered significant when * p < 0.05 (control vs. CMA) groups and # p < 0.05 (CMA vs. CMA + captopril or CM
Figure 10 Chart

Serum sodium and potassium levels measured during chronic metabolic acidosis. Electrolyte imbalances, particularly in potassium homeostasis, are closely linked to both acid-base disturbances and blood pressure regulation through renal and vascular mechanisms.

Chronic Metabolic Acidosis Elicits Hypertension via Upregulation of Intrarenal Angiotensin II and …

Figure 8. Plasma aldosterone (A) and plasma renin (B) analysis. Each bar represents values expressed as mean ± SEM. The changes in plasma aldosterone and renin were considered significant when * p < 0.05 (control vs. CMA) groups. The data were analyzed
Figure 11 Chart

Plasma aldosterone and plasma renin measurements indicate activation of the systemic renin-angiotensin-aldosterone system during chronic metabolic acidosis. Elevated aldosterone levels suggest enhanced sodium retention and potassium excretion as contributors to the hypertensive phenotype.

Chronic Metabolic Acidosis Elicits Hypertension via Upregulation of Intrarenal Angiotensin II and …

Figure 13
Figure 13 Chart

Measured parameters from a study evaluating chronic Metabolic Acidosis Elicits Hypertension via Upregulation of Intrarenal Angiotensin II and Induction of Oxidative Stress, contributing to the overall assessment of chronic metabolic acidosis (CMA) can be a consequence of persistent hypertension but could potentially play a role in.

Chronic Metabolic Acidosis Elicits Hypertension via Upregulation of Intrarenal Angiotensin II and …

Figure 2
Figure 2 Chart

Statistical analysis from research investigating dietary supplements and prevention of preeclampsia, comparing treatment groups and control conditions.

Dietary supplements and prevention of preeclampsia.

Figure 2
Figure 2 Chart

Pharmacological or clinical data supporting quercetin's potential applications for allergic rhinitis, asthma, or related inflammatory conditions.

Quercetin and Its Lecithin-Based Formulation: Potential Applications for Allergic Diseases Based on …

Figure 3
Figure 3 Chart

Comparative efficacy data for quercetin in different formulations, examining the impact of delivery systems on therapeutic outcomes.

Quercetin and Its Lecithin-Based Formulation: Potential Applications for Allergic Diseases Based on …

Figure 3. Plasma concentration of quercetin and its lecithin-based formulation. This pharmacokinetics study compared two groups of healthy volunteers supplemented with quercetin or quercetin phospholipids. Details are reported in the text. Partly modified
Figure 4 Chart

Plasma concentration curves comparing standard quercetin and its lecithin-based (phytosomal) formulation, demonstrating enhanced oral bioavailability of the lipid-based delivery system.

Quercetin and Its Lecithin-Based Formulation: Potential Applications for Allergic Diseases Based on …